These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11897080

  • 1. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology.
    Tacconelli E, Tumbarello M, Bertagnolio S, Citton R, Spanu T, Fadda G, Cauda R.
    Emerg Infect Dis; 2002 Feb; 8(2):220-1. PubMed ID: 11897080
    [No Abstract] [Full Text] [Related]

  • 2. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
    Tumbarello M, Repetto E, Trecarichi EM, Bernardini C, De Pascale G, Parisini A, Rossi M, Molinari MP, Spanu T, Viscoli C, Cauda R, Bassetti M.
    Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
    [Abstract] [Full Text] [Related]

  • 3. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
    Suárez C, Peña C, Tubau F, Gavaldà L, Manzur A, Dominguez MA, Pujol M, Gudiol F, Ariza J.
    J Infect; 2009 Apr; 58(4):285-90. PubMed ID: 19297028
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.
    Hernández-Tejedor A, Merino-Vega CD, Martín-Vivas A, Ruiz de Luna-González R, Delgado-Iribarren A, Gabán-Díez Á, Temprano-Gómez I, de la Calle-Pedrosa N, González-Jiménez AI, Algora-Weber A.
    Infection; 2017 Feb; 45(1):115-117. PubMed ID: 27670678
    [Abstract] [Full Text] [Related]

  • 5. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
    Tam VH, Chang KT, LaRocco MT, Schilling AN, McCauley SK, Poole K, Garey KW.
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
    [Abstract] [Full Text] [Related]

  • 6. A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
    Sun HY, Shields RK, Cacciarelli TV, Muder RR, Singh N.
    Transpl Infect Dis; 2010 Dec; 12(6):555-60. PubMed ID: 20626709
    [Abstract] [Full Text] [Related]

  • 7. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
    Johnson LE, D'Agata EM, Paterson DL, Clarke L, Qureshi ZA, Potoski BA, Peleg AY.
    Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
    [Abstract] [Full Text] [Related]

  • 8. Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.
    Peña C, Gómez-Zorrilla S, Suarez C, Dominguez MA, Tubau F, Arch O, Oliver A, Pujol M, Ariza J.
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2791-7. PubMed ID: 22552893
    [Abstract] [Full Text] [Related]

  • 9. Favorable outcome in a renal transplant recipient with donor-derived infection due to multidrug-resistant Pseudomonas aeruginosa.
    Simkins J, Muggia V.
    Transpl Infect Dis; 2012 Jun; 14(3):292-5. PubMed ID: 22093290
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH, Wang NY, Liu CP, Weng LC, Hsieh FC, Lee CM.
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [Abstract] [Full Text] [Related]

  • 11. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa.
    Nakamura A, Miyake K, Misawa S, Kuno Y, Horii T, Kondo S, Tabe Y, Ohsaka A.
    J Hosp Infect; 2013 Feb; 83(2):153-5. PubMed ID: 23201400
    [Abstract] [Full Text] [Related]

  • 12. Pseudomonas aeruginosa bacteraemia in an academic hospital in South Africa.
    Perovic O, Koornhof HJ, Crewe-Brown HH, Duse AG, van Nierop W, Galpin JS.
    S Afr Med J; 2008 Aug; 98(8):626-32. PubMed ID: 18928043
    [Abstract] [Full Text] [Related]

  • 13. Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.
    Suárez C, Peña C, Gavaldà L, Tubau F, Manzur A, Dominguez MA, Pujol M, Gudiol F, Ariza J.
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e73-8. PubMed ID: 20223693
    [Abstract] [Full Text] [Related]

  • 14. Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum.
    Traugott KA, Echevarria K, Maxwell P, Green K, Lewis JS.
    Pharmacotherapy; 2011 Jun; 31(6):598-608. PubMed ID: 21923444
    [Abstract] [Full Text] [Related]

  • 15. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP, Soares FC, Superti SV, Silbert S, Silva FM, Barth AL.
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract] [Full Text] [Related]

  • 16. Risk factors and prognosis of post-operative pneumonia due to Pseudomonas aeruginosa following cardiac surgery.
    Allou N, Kermarrec N, Muller C, Thabut G, Philip I, Lucet JC, Montravers P.
    J Antimicrob Chemother; 2010 Apr; 65(4):806-7. PubMed ID: 20147323
    [No Abstract] [Full Text] [Related]

  • 17. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005.
    Dejsirilert S, Suankratay C, Trakulsomboon S, Thongmali O, Sawanpanyalert P, Aswapokee N, Tantisiriwat W.
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S68-75. PubMed ID: 21298847
    [Abstract] [Full Text] [Related]

  • 18. The deceased organ donor with an "open abdomen": proceed with caution.
    Watkins AC, Vedula GV, Horan J, Dellicarpini K, Pak SW, Daly T, Samstein B, Kato T, Emond JC, Guarrera JV.
    Transpl Infect Dis; 2012 Jun; 14(3):311-5. PubMed ID: 22283979
    [Abstract] [Full Text] [Related]

  • 19. Pseudomonas aeruginosa bloodstream infections: how should we treat them?
    van Delden C.
    Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S71-5. PubMed ID: 17698326
    [Abstract] [Full Text] [Related]

  • 20. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
    Abdallah HB, Noomen S, Khélifa AB, Sahnoun O, Elargoubi A, Mastouri M.
    Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.